These medications are typically recommended for individuals with a body mass index (BMI) of 30 or higher, or for those with a BMI of 27 or higher with obesity-related comorbidities such as type 2 diabetes or high blood pressure. However, candidacy should be determined by a healthcare provider based on individual health factors and medical history.